CES3 p.Val203Glu
c.608T>A · rs182464715 · VCV2513864
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5555 | ambiguous |
|---|---|---|
| REVEL | 0.71 | pathogenic-leaning |
| SaProt | LLR -12.72 | damaging |
| ⇒ REVEL and SaProt both call this damaging; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.6 | GERP 0.84, phastCons 0.83 |
| Regional constraint | o/e 0.87 | unconstrained · MANE · 12 kb · p 0.00037 · regional, not allelic |
| Overall | ||
| CADD | 24.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0693% | 1,443 |
| Admixed American | 0.00333% | 30,009 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,253 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CES3
- Protein
- p.Val203Glu
- Coding
- c.608T>A
- MANE Select
- NM_024922
- dbSNP
- rs182464715
- Type
- single nucleotide variant
- Location
- chr16:66964404 (GRCh38)
- Gene constraint
- LOEUF 0.987 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 91.89
Similar variants
- CES3 p.Ala133Pro Uncertain significance ★ ⚠ same type
- CES3 p.Ala137Thr Uncertain significance ★ ⚠ same type
- CES3 p.Ala214Val Uncertain significance ★ ⚠ same type
- CES3 p.Ala230Gly Uncertain significance ★ ⚠ same type
- CES3 p.Ala244Thr Uncertain significance ★ ⚠ same type
- CES3 p.Ala408Glu Uncertain significance ★ ⚠ same type
- CES3 p.Ala449Glu Uncertain significance ★ ⚠ same type
- CES3 p.Ala449Val Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ces3-p-val203glu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown